Published in Transfusion on April 14, 2014
Platelet transfusion in hematology, oncology and surgery. Dtsch Arztebl Int (2014) 1.26
Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev (2015) 0.80
Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis. Haematologica (2015) 0.79
Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev (2015) 0.77
A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev (2015) 0.76
Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders. Cochrane Database Syst Rev (2016) 0.75
Indications for platelet transfusion in patients with thrombocytopenia. Blood Transfus (2014) 0.75
Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot study. BMJ Open (2016) 0.75
A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N Engl J Med (2013) 2.90
Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust (2004) 2.74
An update of consensus guidelines for warfarin reversal. Med J Aust (2013) 2.41
Diagnosis and management of iron deficiency anaemia: a clinical update. Med J Aust (2010) 1.78
End-to-end electronic control of the hospital transfusion process to increase the safety of blood transfusion: strengths and weaknesses. Transfusion (2006) 1.71
Transfusing blood safely and appropriately. BMJ (2013) 1.64
Underestimation of myelodysplastic syndrome incidence by cancer registries: Results from a population-based data linkage study. Cancer (2014) 1.50
Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch. Pharmacogenetics (2004) 1.49
Brief review: Supplementing oxygen through an airway exchange catheter: efficacy, complications, and recommendations. Can J Anaesth (2011) 1.48
Factors affecting red blood cell storage age at the time of transfusion. Transfusion (2013) 1.47
The difficult airway with recommendations for management--part 2--the anticipated difficult airway. Can J Anaesth (2013) 1.42
Immunoplatelet counting: potential for reducing the use of platelet transfusions through more accurate platelet counting. Br J Haematol (2003) 1.39
Clinical controversies: etomidate as an induction agent for endotracheal intubation in patients with sepsis: continue to use etomidate for intubation of patients with septic shock. Ann Emerg Med (2008) 1.30
Concepts of blood transfusion in adults. Lancet (2013) 1.28
Age of red blood cells and mortality in the critically ill. Crit Care (2011) 1.15
The difficult airway with recommendations for management--part 1--difficult tracheal intubation encountered in an unconscious/induced patient. Can J Anaesth (2013) 1.08
European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia. Br J Haematol (2003) 1.05
Red cell transfusion for the management of upper gastrointestinal haemorrhage. Cochrane Database Syst Rev (2010) 1.05
Reducing the risk of transfusion-transmissible viral infection through blood donor selection: the Australian experience 2000 through 2006. Transfusion (2007) 1.05
New strategies for the optimal use of platelet transfusions. Hematology Am Soc Hematol Educ Program (2008) 1.04
Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. Cochrane Database Syst Rev (2012) 1.03
Pathogen-reduced platelets for the prevention of bleeding. Cochrane Database Syst Rev (2013) 1.02
What is the maximum time that a unit of red blood cells can be safely left out of controlled temperature storage? Transfus Med Rev (2011) 0.99
Restrictive vs liberal blood transfusion for acute upper gastrointestinal bleeding: rationale and protocol for a cluster randomized feasibility trial. Transfus Med Rev (2013) 0.95
Update on the transfusion in gastrointestinal bleeding (TRIGGER) trial: statistical analysis plan for a cluster-randomised feasibility trial. Trials (2013) 0.93
Cytomegalovirus in pregnancy: to screen or not to screen. BMC Pregnancy Childbirth (2013) 0.91
The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions. Transfusion (2013) 0.91
Challenges and opportunities to prevent transfusion errors: a Qualitative Evaluation for Safer Transfusion (QUEST). Transfusion (2012) 0.90
Red blood cell transfusion for people undergoing hip fracture surgery. Cochrane Database Syst Rev (2015) 0.89
Prevalence, management, and outcomes of patients with coagulopathy after acute nonvariceal upper gastrointestinal bleeding in the United Kingdom. Transfusion (2012) 0.89
Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders. Cochrane Database Syst Rev (2013) 0.88
A review of pathophysiology and current treatment for neonatal alloimmune thrombocytopenia (NAIT) and introducing the Australian NAIT registry. Aust N Z J Obstet Gynaecol (2011) 0.87
The incidence and outcomes of fetomaternal alloimmune thrombocytopenia: a UK national study using three data sources. Br J Haematol (2011) 0.87
HPA-1a phenotype-genotype discrepancy reveals a naturally occurring Arg93Gln substitution in the platelet beta 3 integrin that disrupts the HPA-1a epitope. Blood (2002) 0.86
Red blood cell transfusion practice in patients presenting with acute upper gastrointestinal bleeding: a survey of 815 UK clinicians. Transfusion (2011) 0.86
Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study. Br J Haematol (2014) 0.86
Assessment of the urgency and deferability of transfusion to inform emergency blood planning and triage: the Bloodhound prospective audit of red blood cell use. Transfusion (2009) 0.86
Measurement of phosphatidylserine exposure during storage of platelet concentrates using the novel probe lactadherin: a comparison study with annexin V. Transfusion (2008) 0.85
Small-area analyses of bone cancer diagnosed in Great Britain provide clues to aetiology. BMC Cancer (2012) 0.84
Markers of platelet activation and apoptosis during storage of apheresis- and buffy coat-derived platelet concentrates for 7 days. Transfusion (2008) 0.84
Polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers: seeking confirmation of the association in a follow-up study. Pharmacogenetics (2002) 0.84
Antenatal interventions for fetomaternal alloimmune thrombocytopenia. Cochrane Database Syst Rev (2011) 0.84
Sex and gender in adverse drug events, addiction, and placebo. Handb Exp Pharmacol (2012) 0.83
Standardizing care and monitoring for anesthesia or procedural sedation delivered outside the operating room. Curr Opin Anaesthesiol (2010) 0.83
Retraction. Science (2002) 0.82
Red cell transfusion management for patients undergoing cardiac surgery for congenital heart disease. Cochrane Database Syst Rev (2014) 0.81
The Fastrach Intubating Laryngeal Mask Airway: an overview and update. Can J Anaesth (2010) 0.81
Prophylactic intravenous immunoglobulin during autologous haemopoietic stem cell transplantation for multiple myeloma is not associated with reduced infectious complications. Ann Hematol (2011) 0.81
Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders. Cochrane Database Syst Rev (2015) 0.81
The AABB recommendations for the Choosing Wisely campaign of the American Board of Internal Medicine. Transfusion (2014) 0.81
Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev (2015) 0.80
Inhibition of lectin-like oxidized low-density lipoprotein receptor-1 reduces leukocyte adhesion within the intestinal microcirculation in experimental endotoxemia in rats. Crit Care (2010) 0.80
Platelet transfusion in neonatal alloimmune thrombocytopenia. Blood (2007) 0.80
Hospital blood bank information systems accurately reflect patient transfusion: results of a validation study. Transfusion (2010) 0.79
Blood transfusion safety: the potential role of the patient. Transfus Med Rev (2011) 0.79
Vancomycin and to lesser extent tobramycin have vasomodulatory effects in experimental endotoxemia in the rat. Clin Hemorheol Microcirc (2010) 0.79
Prophylactic platelet transfusions in patients with blood malignancies: cost analysis of a randomized trial. Transfusion (2014) 0.79
Evaluation of the Impact-R for monitoring the platelet storage lesion. Platelets (2009) 0.79
Human platelet antigen 1a epitopes are dependent on the cation-regulated conformation of integrin α(IIb)β(3) (GPIIb/IIIa). J Immunol Methods (2011) 0.79
Is fluoride a risk factor for bone cancer? Small area analysis of osteosarcoma and Ewing sarcoma diagnosed among 0-49-year-olds in Great Britain, 1980-2005. Int J Epidemiol (2014) 0.78
Legal and ethical issues in blood transfusion. Br J Hosp Med (Lond) (2013) 0.78
Effect of six months of treatment with V0191 in patients with suspected prodromal Alzheimer's disease. J Alzheimers Dis (2012) 0.78
Wrong blood in tube - potential for serious outcomes: can it be prevented? Br J Haematol (2014) 0.78
Hemoglobin and iron indices in nonanemic premenopausal blood donors predict future deferral from whole blood donation. Transfusion (2011) 0.78
Red cell transfusion for the management of upper gastrointestinal haemorrhage. Cochrane Database Syst Rev (2009) 0.77
Low frequency of anti-D alloimmunization following D+ platelet transfusion: the Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study. Br J Haematol (2014) 0.77
High incidence of defective high-shear platelet function among platelet donors. Transfusion (2004) 0.77
Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev (2015) 0.77
Blood transfusion requirements for patients undergoing chemotherapy for acute myeloid leukemia how much is enough? Haematologica (2007) 0.77
Streptococcus pneumoniae septicemia associated with red blood cell transfusion. Transfusion (2008) 0.76
Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev (2016) 0.76
A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev (2015) 0.76
Clinical transfusion practice update: haemovigilance, complications, patient blood management and national standards. Med J Aust (2013) 0.76
N-Acetylcysteine for thrombotic thrombocytopenic purpura: is a von Willebrand factor-inhibitory dose feasible in vivo? Transfusion (2014) 0.76
Myelodysplastic syndrome incidence, transfusion dependence, health care use, and complications: an Australian population-based study 1998 to 2008. Transfusion (2013) 0.76
Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders. Cochrane Database Syst Rev (2016) 0.76
Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review. Cochrane Database Syst Rev (2016) 0.75
Plasma transfusions prior to insertion of central lines for people with abnormal coagulation. Cochrane Database Syst Rev (2016) 0.75
Bringing the larynx into view: a piece of the puzzle. Ann Emerg Med (2003) 0.75
Transfusion medicine reviews special edition: focus on Australia. Transfus Med Rev (2015) 0.75
A review on decision support for massive transfusion: understanding human factors to support the implementation of complex interventions in trauma. Transfusion (2012) 0.75
Interventions to reduce wrong blood in tube errors in transfusion: a systematic review. Transfus Med Rev (2013) 0.75
Prophylactic platelet transfusions. Curr Opin Hematol (2010) 0.75
Effect of restrictive versus liberal red cell transfusion strategies on haemostasis: systematic review and meta-analysis. Thromb Haemost (2017) 0.75
Interventions for chronic kidney disease in people with sickle cell disease. Cochrane Database Syst Rev (2017) 0.75
A dynamic mathematical model of red blood cell clinical demand to assess the impact of prolonged blood shortages and transfusion restriction policies. Transfusion (2014) 0.75
Desmopressin use for minimising perioperative blood transfusion. Cochrane Database Syst Rev (2017) 0.75